Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
Louis M KwongDepartment of Orthopedic Surgery, Harbor-UCLA Medical Center, Torrance, CA, USAAbstract: Routine thromboprophylaxis represents the current standard of care in the management of patients following total hip or knee replacement. Legacy agents used to address the issue of risk of venous th...
Enregistré dans:
Auteur principal: | Kwong LM |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9a6b65f9b54544fba836e20c1e33317a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Venous thromboembolism in patients hospitalized for knee joint replacement surgery
par: Karsten Keller, et autres
Publié: (2020) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
par: Victoria Speed, et autres
Publié: (2021) -
Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis
par: Qing An, et autres
Publié: (2021) -
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
par: Ikuo Fukuda, et autres
Publié: (2021) -
Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
par: Bosch A, et autres
Publié: (2020)